CDKN2B and breast carcinoma: Finally, it has been shown that CDKN2B-AS1 regulates the expression of STK39 by acting as a sponge for hsa-mir-122-5p, thereby promoting breast cancer progression, and hsa-mir-122-5p modulates STK39 expression to regulate the impact of sh-CDKN2B-AS1 [42].